Les Industries Dorel tiendra une téléconférence pour discuter des résultats de son premier trimestre
May 02, 2024 08:30 ET
|
Les Industries Dorel Inc.
MONTRÉAL, 02 mai 2024 (GLOBE NEWSWIRE) -- Les Industries Dorel Inc. (TSX : DII.B, DII.A) TÉLÉCONFÉRENCE :OUVERTE AUX :Analystes, investisseurs et autres personnes intéresséesDATE :Le vendredi...
Dorel Industries Will Hold a Conference Call to Discuss Its First Quarter Results
May 02, 2024 08:30 ET
|
Dorel Industries, Inc.
MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Dorel Industries, Inc. (TSX: DII.B, DII.A) CONFERENCE CALL:OPEN TO:Analysts, investors and all interested partiesDATE:Friday, May 10, 2024TIME:1:00 PM...
WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI
May 02, 2024 08:00 ET
|
HEALWELL AI Inc.
WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI
GURU Organic Energy fait son entrée dans le segment sans sucre avec GURU Zéro Baies sauvages qui boost le métabolisme
May 02, 2024 07:30 ET
|
GURU Organic Energy Corp.
ZÉRO SUCRE : le segment des boissons énergisantes qui connaît la plus forte croissance au Québec1 et aux États-Unis2, alors que plus de consommateurs recherchent des boissons énergisantes à faible...
GURU Organic Energy Enters Zero Sugar Segment With Metabolism-Boosting GURU Zero Wild Berry
May 02, 2024 07:30 ET
|
GURU Organic Energy Corp.
ZERO SUGAR: fastest growing energy drink segment in Quebec1 and the US2 as more consumers seek low-calorie, sugar-free energy drinks.METABOLISM BOOST: EGCG and catechins, a form of green tea...
Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du premier trimestre 2024
May 02, 2024 07:30 ET
|
Thérapeutique Knight inc.
MONTRÉAL, 02 mai 2024 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (ex. EU) et chef de file, publiera ses résultats...
Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call
May 02, 2024 07:30 ET
|
Knight Therapeutics
MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its first quarter 2024...
Stack Capital Group Inc. Reports Q1-24 Financial Results
May 02, 2024 07:30 ET
|
Stack Capital Group Inc.
Stack Capital Group Inc. (TSX: STCK and STCK.WT) today announced its financial results for the quarter ended March 31, 2024.
VitalHub Announces Q1 2024 Conference Call Date
May 02, 2024 07:30 ET
|
VitalHub Corp.
TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSX: VHI) (OTCQX:VHIBF) is pleased to announce that it will release its financial results for its first...
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
May 02, 2024 07:30 ET
|
Theratechnologies
First long-term data presentation from Parts 1 and 2 of the Phase 1 clinical trial of sudocetaxel zendusortide in solid tumors Part 3 of Phase 1 trial in advanced ovarian cancer is ongoing MONTREAL,...